Clindamycin Phosphate
Product Images NDC 54868-5307

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate (NDC 54868-5307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Clindamycin Phosphate Vaginal Cream 01)

Chemical structure of the active ingredient Clindamycin Phosphate, showing its molecular components and bond arrangement.*

FDA Label Image

Figure (Clindamycin Phosphate Vaginal Cream 02)

A data table showing reported adverse events for Clindamycin Phosphate Vaginal Cream during 3-day and 7-day treatments. Events include urogenital issues such as vaginal moniliasis, vulvovaginitis, vulvovaginal disorder, and trichomonal vaginitis, as well as body-wide moniliasis occurrences, with corresponding numeric values for each treatment duration group.*

FDA Label Image

Figure (Clindamycin Phosphate Vaginal Cream 03)

A data table comparing the incidence of adverse events between Clindamycin and Placebo groups over 7 days. Events are categorized under Urogenital, Body as a Whole, and Skin, with percentages shown for vaginal moniliasis, vulvovaginal disorder, abnormal labor, fungal infection, and pruritus at a non-application site.*

FDA Label Image

Figure (Clindamycin Phosphate Vaginal Cream 04)

An instructional line drawing showing hands assembling or preparing a syringe or similar medical device. The diagram highlights hand positioning while handling the device components, including a cylindrical part and a connected needle or applicator tip.*

FDA Label Image

Figure (Clindamycin Phosphate Vaginal Cream 05)

An anatomical illustration showing a hand inserting a device into the vagina, labeled with the vagina, cervix, and rectum for spatial orientation. The diagram depicts the relative positions of these anatomical structures in a sagittal view.*

FDA Label Image

Figure (Clindamycin Phosphate Vaginal Cream 06)

An instructional diagram showing hands assembling or attaching a syringe to a vial or cartridge, likely depicting the preparation process for an injectable medication.*

FDA Label Image

Figure (Clindamycin Phosphate Vaginal Cream 07)

An anatomical diagram illustrating the insertion of a vaginal applicator with labeled parts: vagina, cervix, and rectum. The diagram shows the hand holding the applicator positioned inside the vaginal canal near the cervix.*

FDA Label Image

40 Gram Carton (Cream Package Label)

Packaging label for Clindamycin Phosphate Vaginal Cream 2% distributed by Physicians Total Care, Inc., Tulsa, OK. The label includes the NDC 54868-5307-0, lot number 0000, expiration date 01/60, and manufacturing information for E. Fougera & Co., Melville, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.